Primary Healthcare Properties delivers 10.5% NAV uplift – Primary Healthcare Properties (PHP) has published its results for the year ended 31 December 2017. Highlights were: EPRA earnings increased by 15.7% to GBP31.0m (2016: GBP26.8m) EPRA earnings per share increased by 8.3% to 5.2p (2016: 4.8p) Net rental income increased by 7.1% to GBP71.3m (2016: GBP66.6m) IFRS […]
Trust favourite Biogen hit by AD trial rejig – Shares in Biogen, the neurology-focused US biotech giant and a key holding for many of the sector specialist investment trusts, fell by more than 6% yesterday on heightened concerns over a decision to expand patient enrolment in its two large Phase III trials of aducanumab for […]
Brunner – 46 years of dividend growth. Brunner has announced its final Results for the year ended 30 November 2017. Its NAV total return was 19.5%, which is ahead of its composite benchmark index’s return of 15.1%. In terms of specific drivers of performance, the extract from the annual report released this morning does not […]
Talib Sheikh leaves JPMorgan Asset Management – JPMorgan Income & Capital Trust published a circular on 25 January 2018 in connection with the reconstruction of the company. Shareholders are being offered the choice of: (i) a tax and cost efficient rollover into JPMorgan Multi-Asset Trust plc (“MATE“); and/or (ii) cash. MATE’s portfolio will be managed […]
UEM relocating to the UK – Having announced on 21 November 2017 that it was considering options for a possible change in its domicile from Bermuda to the UK, the Board of Utilico Emerging Markets Limited (UEM) has decided that it would be in the Company’s best interests to re-domicile the Company to the United […]
BBH’s first annual report delivers positive news- BBH has announced results for the year ended 30 November 2017, over the period the total return was 19.3%, an outperformance of 4.9% versus the benchmark (the MSCI World Healthcare Total Return Index in GBP). The total return for shareholders was 20.5%. Total dividends for the year were 3.5p. For the […]
IBT key beneficiary of massive BMS-Nektar deal – International Biotech Trust (IBT) looks set to be the main investment trust beneficiary of the massive deal signed today between Bristol-Myers Squibb (BMS) and Nektar Therapeutics covering what had hitherto been – albeit briefly – the industry’s hottest un-partnered cancer drug, NKTR-214. Nektar is the third largest shareholding for […]
Aberdeen Asian Smaller considering new CULS issue – The board of Aberdeen Asian Smaller Companies has commissioned its advisers to develop a detailed proposal to the company’s shareholders and CULS holders in relation to restructuring the current CULS. The proposal is currently being formulated but is expected to include: a conversion of the existing CULS […]
Blackstone GSO Loan Financing comments on US court decision – on Friday, 9 February 2018, the U.S. Court of Appeals for the D.C. Circuit ruled in favour of the Loan Syndications and Trading Association (“LSTA”) in its lawsuit against the U.S. Securities and Exchange Commission (“SEC”) and the Federal Reserve, determining that U.S. CLO managers […]
LXi fully invested again after social housing deal – LXi REIT has exchanged contracts on the acquisition of the freehold interest in a portfolio of regulated long-let supported living properties located in Colchester, Essex (74%), Birmingham (17%) and Dover, Kent (9%). The purchase price for this portfolio is GBP6.2 million, reflecting a net initial yield of […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated
